RE:RE:RE:RE:Tomorrows Webinar3-4 months for this kind of work may be fast, I don't know. I would have thought that anybody testing this device would also have to test the cartridge as well. And if a cartridge has a 3-month life without detection, wouldn't the actual testing have to last at least three months, otherwise you are relying on theoretical principles, which then should be fullproof? But, throwing in the statement about government agencies, I again have issues with its communication. They threw out this item that can let imagination go wild, yet in their projection, they seemed not to allow for any such contingencies. Yes, it was "current visibility" of sales, but they could have qualitatively described what that includes and the potential it doesn't include. Some people were guessing that this was the demise of the 20,000 monthly units, but I am far from convinced that their initial expectations and model was geared 99%+ toward Canadian governments purchase expectations.
KNRfan wrote: canyousayiii wrote: I hope they mention HC, but I don't see it as a broken promise since HC is in the driver's seat. They expected results in July at that time and obviously things did not go according to plan or forever reasons HC has not given them the green light to release the results. Perhaps we should call investor relations like Wilander suggest and go a step further and ask them to provide us the slide deck. If Paul will gloss over BioCloud in a sentence or two, one of them indicating no further details will be provided, nothing good can be interpreted from that and then he would have continued sending mixed signals, that are prone to being misinterpreted. Let's see how he does.
KNRfan wrote: wilander wrote: For those actual investors wondering about the webinar you don't have to play the "gee i wonder what its about game"all day. All you have to do is contact investor relations. The webinar will focus primarily on the acquisition and its positive implications going forward for the business. Paul will also touch on a few other updates on things that have been in the works. Beyond that, management will give a more all encompassing update on the next earnings call.
Then it isn't worth listening to. And the fact they have failed once again, this time not meeting their timeline on the Health Canada review, is just one more broken promise.
Considering this is about Covid, and "
The testing is carried out at the request of several interested government agencies" I would have thought Health Canada might have put a bit of urgency on this project.